Russell Investments »

Actuate Therapeutics shares owned by Russell Investments

Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by Russell Investments from 13F filings

Historical chart of Russell Investments investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by Russell Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by Russell Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.3k 487 6.69

More positions owned by Russell Investments

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Meta Platforms Common Stock (META)
Alphabet Common Stock (GOOGL)
Alphabet Common Stock (GOOG)
Broadcom Common Stock (AVGO)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Mastercard Incorporated Common Stock (MA)
Tesla Common Stock (TSLA)
Welltower Common Stock (WELL)
J P Morgan Chase And Common Stock (JPM)
Visa Common Stock (V)
Oracle Corp Common Stock (ORCL)

View all positions for Russell Investments

Top funds holding Actuate Therapeutics

BIOS Capital Management
Voss Capital
Vanguard Group
BlackRock
Geode Capital Management
Northern Trust
State Street Corporation
Northwestern Mutual Wealth Management Company
Gleason Group
SFMG Wealth Advisors
LPL Financial
Charles Schwab Investment Management
Wells Fargo & Company
Royal Bank of Canada
Freestone Capital Holdings

View all funds holding Actuate Therapeutics